Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec 15.
doi: 10.1038/s41598-025-32422-y. Online ahead of print.

Protein domain-specific genotype-phenotype correlation study of neurofibromatosis type 1

Affiliations
Free article

Protein domain-specific genotype-phenotype correlation study of neurofibromatosis type 1

Min Ou et al. Sci Rep. .
Free article

Abstract

Neurofibromatosis type 1 (OMIM 613,113, NF1) is a neurocutaneous disorder caused by pathogenic genetic alteration in NF1 gene, which exhibits nearly full penetrance and affects multiple systems. Previously two association studies of optic pathway glioma and NF1 protein domains, derived from 215 and 381 patients, respectively, obtained contradicting results, reflecting different datasets can lead to different conclusions and there is a need for a larger dataset to reach a solid conclusion. There is another association study based on 832 patients considering protein domains, clinical features, and types of variants. But it only investigated the GTPase-activating protein domain and non-truncating variants. In this study, an extended association analysis involving eight protein domains, two types of variants, namely truncating and non-truncating variants, and 32 clinical features, was performed based on a combined dataset of 1663 NF1 patients consisting of 738 cases recruited in Hong Kong and 925 reported cases from 25 studies. In summary, this study has identified 121 statistically significant associations between clinical features, types of variants, and protein domains, with 120 of them being novel findings. These new insights about the genotype-phenotype association promote better clinical management.

Keywords: Domain; Genotype–phenotype association; Neurofibromatosis type 1; Non-truncating variants; Noonan-syndrome; Truncating variants.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

References

    1. Isakov, O., Wallis, D., Evans, D. G. & Ben-Shachar, S. Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture. EBioMedicine 36, 508–516. https://doi.org/10.1016/j.ebiom.2018.09.039 (2018).
    1. Kiuru, M. & Busam, K. J. The NF1 gene in tumor syndromes and melanoma. Lab. Invest. 97, 146–157. https://doi.org/10.1038/labinvest.2016.142 (2017).
    1. Ratner, N. & Miller, S. J. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat. Rev. Cancer 15, 290–301. https://doi.org/10.1038/nrc3911 (2015).
    1. Xu, M. et al. Identification of mutation regions on NF1 responsible for high- and low-risk development of optic pathway glioma in neurofibromatosis type I. Front. Genetics 9, 270. https://doi.org/10.3389/fgene.2018.00270 (2018).
    1. Legius, E. et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet. Med. 23, 1506–1513. https://doi.org/10.1038/s41436-021-01170-5 (2021).

LinkOut - more resources